KIF1B and primary biliary cholangitis: Examination of anti-MIT3-negative PBC patients in the five cohorts showed a prevalence of anti-HK-1 antibodies ranging from 11.8–40.0% and anti-KL-p antibodies from 10.3 to 80.0% (Table 1).